These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Insights into the genetic and molecular basis of primary pulmonary hypertension. Trembath RC; Harrison R Pediatr Res; 2003 Jun; 53(6):883-8. PubMed ID: 12621102 [TBL] [Abstract][Full Text] [Related]
9. Specific bone morphogenic protein receptor II mutations found in primary pulmonary hypertension cause different biochemical phenotypes in vitro. Thomas AQ; Carneal J; Markin C; Lane KB; Phillips JA; Loyd JE; Gaddipati R Chest; 2002 Mar; 121(3 Suppl):83S. PubMed ID: 11893707 [No Abstract] [Full Text] [Related]
10. The mouse through the looking glass: a new door into the pathophysiology of pulmonary hypertension. Rabinovitch M Circ Res; 2004 Apr; 94(8):1001-4. PubMed ID: 15117827 [No Abstract] [Full Text] [Related]
11. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Machado RD; Rudarakanchana N; Atkinson C; Flanagan JA; Harrison R; Morrell NW; Trembath RC Hum Mol Genet; 2003 Dec; 12(24):3277-86. PubMed ID: 14583445 [TBL] [Abstract][Full Text] [Related]
12. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma? Stewart DJ Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025 [No Abstract] [Full Text] [Related]
14. Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases. Tew MB; Arnett FC; Reveille JD; Tan FK Arthritis Rheum; 2002 Oct; 46(10):2829-30. PubMed ID: 12384956 [No Abstract] [Full Text] [Related]
15. [Pulmonary hypertension in rheumatic diseases]. Lang IM; Bonderman D; Skoro-Sajer N; Klepetko W; Kneussl M Z Rheumatol; 2003 Feb; 62(1):2-9. PubMed ID: 12624796 [TBL] [Abstract][Full Text] [Related]
16. Signaling molecules in nonfamilial pulmonary hypertension. Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. Morse J; Barst R; Horn E; Cuervo N; Deng Z; Knowles J J Rheumatol; 2002 Nov; 29(11):2379-81. PubMed ID: 12415595 [TBL] [Abstract][Full Text] [Related]
18. [Mutations of genes coding for TGF-beta receptors (BMPR2 and ALK-1) in primary pulmonary arterial hypertension]. Humbert M J Soc Biol; 2002; 196(1):53-8. PubMed ID: 12134634 [TBL] [Abstract][Full Text] [Related]
19. Linkage analysis in a large family with primary pulmonary hypertension: genetic heterogeneity and a second primary pulmonary hypertension locus on 2q31-32. Janssen B; Rindermann M; Barth U; Miltenberger-Miltenyi G; Mereles D; Abushi A; Seeger W; Kübler W; Bartram CR; Grünig E Chest; 2002 Mar; 121(3 Suppl):54S-56S. PubMed ID: 11893685 [No Abstract] [Full Text] [Related]